The landscape of biopharmaceutical manufacturing in Ireland has recently welcomed an impressive addition with the inauguration of the National Institute for Bioprocessing Research and Training's (NIBRT) new facility. This state-of-the-art establishment in Dublin, conceived with a robust €21 million
In a significant move aimed at boosting the development of cell and gene therapies, Bionova Scientific, a part of the Asahi Kasei Group, has announced an ambitious $100 million investment. This investment will see the creation of a new state-of-the-art plasmid DNA (pDNA) production facility in The
AstraZeneca, the renowned pharmaceutical giant, has unveiled plans to invest $1.5 billion in a cutting-edge antibody drug conjugate (ADC) manufacturing facility in Singapore, marking a significant milestone in the company's history. The state-of-the-art factory is poised to become operational in
Solvias' announcement of opening a new biotech facility in Research Triangle Park, North Carolina, has sparked excitement and anticipation within the Raleigh-Durham area. The region, already renowned for its concentration of tech and biotech firms, is poised to add another jewel to its crown with
ChargePoint Technology is taking a significant leap to scale up its manufacturing capabilities amid surging demand for single-use disposable systems in the pharmaceutical sector. By pouring investment into a state-of-the-art facility in Speke, Liverpool, the company aims to strengthen its position
In a groundbreaking initiative, Moderna has joined forces with AI powerhouse OpenAI to revolutionize vaccine development through artificial intelligence. This move signifies a fusion of Moderna's medical prowess with OpenAI's advanced AI technology. Together, they seek to transform the way vaccines
